However, when patients were considered individually, those exhibiting the largest reductions in serum insulin, tumor IR expression and p-Akt (as a summary variable) exhibited the largest reductions in tumor cell proliferation (r = 0.41, P = 0.012) (Additional file 8). The gene discussed is AKT1; the disease is neoplasm.